NYSE:DVADavita Stock Price, Forecast & News

Davita's stock was trading at $74.87 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, DVA shares have increased by 9.8% and is now trading at $82.17.
View which stocks have been most impacted by COVID-19.

10 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Davita in the last year. There are currently 8 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Hold."
View analyst ratings for Davita.

Davita is scheduled to release its next quarterly earnings announcement on Tuesday, November 3rd 2020.
View our earnings forecast for Davita.

Davita Inc (NYSE:DVA) released its quarterly earnings data on Thursday, July, 30th. The company reported $1.95 EPS for the quarter, topping analysts' consensus estimates of $1.30 by $0.65. The firm earned $2.88 billion during the quarter, compared to the consensus estimate of $2.91 billion. Davita had a return on equity of 40.78% and a net margin of 7.20%.
View Davita's earnings history.

Davita issued an update on its FY20 earnings guidance on Thursday, July, 30th. The company provided earnings per share guidance of $6.25-$6.75 for the period, compared to the Thomson Reuters consensus estimate of $6.11. The company issued revenue guidance of $11.5-$11.7 billion, compared to the consensus revenue estimate of $11.70 billion.

10 Wall Street analysts have issued twelve-month target prices for Davita's stock. Their forecasts range from $57.00 to $100.00. On average, they anticipate Davita's stock price to reach $71.17 in the next twelve months. This suggests that the stock has a possible downside of 13.4%.
View analysts' price targets for Davita.

News headlines about DVA stock have trended neutral on Saturday, according to InfoTrie Sentiment Analysis. The research group rates the sentiment of news coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Davita earned a daily sentiment score of 0.2 on InfoTrie's scale. They also assigned news stories about the company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an effect on the stock's share price in the next few days.
View the latest news about Davita.

Davita saw a decrease in short interest during the month of February. As of February 15th, there was short interest totaling 5,540,000 shares, a decrease of 18.6% from the January 31st total of 6,810,000 shares. Based on an average daily trading volume, of 1,260,000 shares, the short-interest ratio is presently 4.4 days. Approximately 4.5% of the company's shares are short sold.
View Davita's Short Interest.

Some companies that are related to Davita include Laboratory Corp. of America (LH), Quest Diagnostics (DGX), Chemed (CHE), Amedisys (AMED), LHC Group (LHCG), AMN Healthcare Services (AMN), R1 RCM (RCM), MEDNAX (MD), CorVel (CRVL), The Providence Service (PRSC), Tivity Health (TVTY), Cross Country Healthcare (CCRN) and Interpace Diagnostics Group (IDXG).
View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Davita investors own include CA (CA), BlackRock (BLK), Chipotle Mexican Grill (CMG), Endologix (ELGX), Micron Technology (MU), Aegean Marine Petroleum Network (ANW), AbbVie (ABBV), AT&T (T), AutoZone (AZO) and United Rentals (URI).

Davita trades on the New York Stock Exchange (NYSE) under the ticker symbol "DVA."

Davita's stock is owned by many different retail and institutional investors. Top institutional shareholders include Vanguard Group Inc. (8.28%), Bank of New York Mellon Corp (2.22%), Par Capital Management Inc. (1.71%), Robeco Institutional Asset Management B.V. (1.38%), LSV Asset Management (0.82%) and Bank of America Corp DE (0.50%). Company insiders that own Davita stock include Charles Berg, John M Nehra, Kent J Thiry, Pamela M Arway and Paul J Diaz.
View institutional ownership trends for Davita.

DVA stock was sold by a variety of institutional investors in the last quarter, including Par Capital Management Inc., Vanguard Group Inc., First Trust Advisors LP, Canada Pension Plan Investment Board, AJO LP, Sumitomo Mitsui Trust Holdings Inc., Prudential Financial Inc., and Glenmede Trust Co. NA. Company insiders that have sold Davita company stock in the last year include Charles Berg, John M Nehra, Kent J Thiry, Pamela M Arway, and Paul J Diaz.
View insider buying and selling activity for Davita.

DVA stock was purchased by a variety of institutional investors in the last quarter, including State of Michigan Retirement System, LSV Asset Management, Todd Asset Management LLC, Bellevue Group AG, Robeco Institutional Asset Management B.V., Achmea Investment Management B.V., First Eagle Investment Management LLC, and Victory Capital Management Inc..
View insider buying and selling activity for Davita.

Shares of DVA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of DVA stock can currently be purchased for approximately $82.17.

Davita has a market capitalization of $10.02 billion and generates $11.39 billion in revenue each year. The company earns $810.98 million in net income (profit) each year or $5.40 on an earnings per share basis. Davita employs 65,000 workers across the globe.

The official website for Davita is www.davita.com.

Davita's mailing address is 2000 16TH STREET, DENVER CO, 80202. The company can be reached via phone at 720-631-2100 or via email at [email protected]